Finally, and in line with data presented here indicating that SUMOylation is required for ERK5 nuclear translocation, we show that SUMO modification is necessary for ERK5-induced AP-1-mediated proliferation of prostatic adenocarcinoma PC-3 cells (Figure 5B,C). The gene discussed is MAPK7; the disease is prostate adenocarcinoma.